Search Results

There are 27386 results for: content related to: Sunitinib-induced hand–foot syndrome in a renal cell carcinoma: A sclerodermatous and rheumatoid arthritis-like case

  1. You have free access to this content
    Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy

    International Journal of Cancer

    Volume 130, Issue 8, 15 April 2012, Pages: 1948–1959, Benedetto Farsaci, Jack P. Higgins and James W. Hodge

    Article first published online : 8 AUG 2011, DOI: 10.1002/ijc.26219

  2. You have full text access to this OnlineOpen article
    Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib

    Journal of Cellular and Molecular Medicine

    Volume 19, Issue 2, February 2015, Pages: 430–441, Eva Juengel, Dana Kim, Jasmina Makarević, Michael Reiter, Igor Tsaur, Georg Bartsch, Axel Haferkamp and Roman A. Blaheta

    Article first published online : 2 DEC 2014, DOI: 10.1111/jcmm.12471

  3. You have full text access to this OnlineOpen article
    Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction

    Cancer Medicine

    Volume 4, Issue 7, July 2015, Pages: 1003–1015, Esther A. Kleibeuker, Matthijs A. ten Hooven, Kitty C. Castricum, Richard Honeywell, Arjan W. Griffioen, Henk M. Verheul, Ben J. Slotman and Victor L. Thijssen

    Article first published online : 31 MAR 2015, DOI: 10.1002/cam4.441

  4. You have free access to this content
    Sunitinib malate in the treatment of renal cell carcinoma and gastrointestinal stromal tumor: Recommendations for patient management

    Asia-Pacific Journal of Clinical Oncology

    Volume 3, Issue 4, December 2007, Pages: 167–176, Jayesh DESAI, Howard GURNEY, Nick PAVLAKIS, Grant A McARTHUR and Ian D DAVIS

    Article first published online : 3 DEC 2007, DOI: 10.1111/j.1743-7563.2007.00136.x

  5. You have full text access to this OnlineOpen article
    Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment

    Cancer Science

    Volume 106, Issue 2, February 2015, Pages: 160–170, Gökçe Hatipoglu, Stefan W. Hock, Ruth Weiss, Zheng Fan, Tina Sehm, Ali Ghoochani, Michael Buchfelder, Nicolai E. Savaskan and Ilker Y. Eyüpoglu

    Article first published online : 15 FEB 2015, DOI: 10.1111/cas.12580

  6. You have free access to this content
    Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease

    Arthritis & Rheumatism

    Volume 64, Issue 6, June 2012, Pages: 1990–2000, Niloufar Kavian, Amélie Servettaz, Wioleta Marut, Carole Nicco, Christiane Chéreau, Bernard Weill and Frédéric Batteux

    Article first published online : 25 MAY 2012, DOI: 10.1002/art.34354

  7. You have free access to this content
    Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma


    Volume 118, Issue 5, 1 March 2012, Pages: 1252–1259, Carlos H. Barrios, David Hernandez-Barajas, Michael P. Brown, Se-Hoon Lee, Luis Fein, Jin-Hwang Liu, Subramanian Hariharan, Bridget A. Martell, Jinyu Yuan, Akintunde Bello, Zhixiao Wang, Rajiv Mundayat and Sun-Young Rha

    Article first published online : 6 SEP 2011, DOI: 10.1002/cncr.26440

  8. Sorafenib and Sunitinib: Novel Targeted Therapies for Renal Cell Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 8, August 2007, Pages: 1125–1144, Dr. Cheryl A. Grandinetti and Dr. Barry R. Goldspiel

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.27.8.1125

  9. You have free access to this content
    Management of sunitinib adverse events in renal cell carcinoma patients: The Asian experience

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 2, June 2012, Pages: 132–144, Aiping ZHOU

    Article first published online : 24 APR 2012, DOI: 10.1111/j.1743-7563.2012.01525.x

  10. You have full text access to this Open Access content
    Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer

    Cancer Science

    Volume 102, Issue 11, November 2011, Pages: 1949–1957, Takeshi Yuasa, Shunji Takahashi, Kiyohiko Hatake, Junji Yonese and Iwao Fukui

    Article first published online : 14 SEP 2011, DOI: 10.1111/j.1349-7006.2011.02054.x

  11. Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment-use trial of sunitinib


    Volume 121, Issue 9, May 1, 2015, Pages: 1405–1413, Peter Reichardt, Yoon-Koo Kang, Piotr Rutkowski, Jochen Schuette, Lee S. Rosen, Beatrice Seddon, Suayib Yalcin, Hans Gelderblom, Charles C. Williams Jr, Elena Fumagalli, Guido Biasco, Herbert I. Hurwitz, Pamela E. Kaiser, Kolette Fly, Ewa Matczak, Liang Chen, Maria José Lechuga and George D. Demetri

    Article first published online : 13 JAN 2015, DOI: 10.1002/cncr.29220

  12. Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 237–245, Se-Hoon Lee, Yung-Jue Bang, Paul Mainwaring, Christina Ng, John W-C Chang, Philip Kwong, Rubi K Li, Virote Sriuranpong, Chee-Keong Toh, Jinyu Yuan, Susan Pitman Lowenthal and Hyun C Chung

    Article first published online : 27 FEB 2014, DOI: 10.1111/ajco.12163

  13. You have free access to this content
    PRKX, TTBK2 and RSK4 expression causes sunitinib resistance in kidney carcinoma- and melanoma-cell lines

    International Journal of Cancer

    Volume 131, Issue 2, 15 July 2012, Pages: E45–E55, Claus Bender and Axel Ullrich

    Article first published online : 28 FEB 2012, DOI: 10.1002/ijc.26486

  14. You have free access to this content
    Sunitinib-induced hyperparathyroidism


    Volume 118, Issue 12, 15 June 2012, Pages: 3165–3172, Valentina Baldazzi, Renato Tassi, Alberto Lapini, Alice Lunghi, Eleonora Garofoli, Salvatore Caruso, Marco Carini and Roberto Mazzanti

    Article first published online : 28 SEP 2011, DOI: 10.1002/cncr.26435

  15. You have free access to this content
    Combination of sunitinib with anti-tumor vaccination inhibits T cell priming and requires careful scheduling to achieve productive immunotherapy

    International Journal of Cancer

    Volume 134, Issue 7, 01 April 2014, Pages: 1695–1705, Ritika Jaini, Patricia Rayman, Peter A. Cohen, James H. Finke and Vincent K. Tuohy

    Article first published online : 8 OCT 2013, DOI: 10.1002/ijc.28488

  16. You have full text access to this OnlineOpen article
    IGF-1 receptor is down-regulated by sunitinib induces MDM2-dependent ubiquitination

    FEBS Open Bio

    Volume 2, Issue 1, January 01, 2012, Pages: 1–6, Hongchang Shen, Yan Fang, Wei Dong, Xueru Mu, Qi Liu and Jiajun Du

    Article first published online : 27 DEC 2011, DOI: 10.1016/j.fob.2011.12.001

  17. You have free access to this content
    Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders

    British Journal of Pharmacology

    Volume 171, Issue 24, December 2014, Pages: 5757–5773, Wolf Wrasidlo, Leslie A Crews, Igor F Tsigelny, Emily Stocking, Valentina L Kouznetsova, Diana Price, Amy Paulino, Tania Gonzales, Cassia R Overk, Christina Patrick, Edward Rockenstein and Eliezer Masliah

    Article first published online : 1 DEC 2014, DOI: 10.1111/bph.12875

  18. You have free access to this content
    A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061


    Volume 120, Issue 8, 15 April 2014, Pages: 1194–1202, Michelle A. Rudek, Page C. Moore, Ronald T. Mitsuyasu, Bruce J. Dezube, David Aboulafia, John Gerecitano, Ryan Sullivan, Mary E. Cianfrocca, David H. Henry, Lee Ratner, Missak Haigentz, Afshin Dowlati, Richard F. Little, Susan Percy Ivy and John F. Deeken

    Article first published online : 28 JAN 2014, DOI: 10.1002/cncr.28554

  19. The evaluation of efficacy and safety of sunitinib on EGFR-TKI pretreated advanced non-small cell lung cancer patients in China

    The Clinical Respiratory Journal

    Volume 8, Issue 2, April 2014, Pages: 206–212, You-ru Liu, Wei Zhu, Jian-liang Zhang, Jia-qi Huang, Yi-zhuo Zhao, Wei Zhang, Bao-hui Han, Yi-hong Yao, Li-yan Jiang and Shan-qun Li

    Article first published online : 11 DEC 2013, DOI: 10.1111/crj.12059

  20. Targeted therapy for advanced renal cell carcinoma

    Intervention Review

    The Cochrane Library

    Chris Coppin, Lyly Le, Timothy J Wilt and Christian Kollmannsberger

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006017.pub2